Tastemaker Acquisition Corp. (TMKR) Adjourns Meeting, Changes Name to Priveterra II
by Nicholas Alan Clayton on 2023-07-10 at 3:28pm

Tastemaker Acquisition Corp. (NASDAQ:TMKR) announced in an 8-K this afternoon that adjourned its extension vote this morning and will reopen it at 3 pm ET July 11.

The SPAC has traded below its redemption rate $10.70 in recent weeks and last closed at $10.57. Tastemaker (now Priveterra II) aims to spend the extra time engaging with shareholders and one topic of conversation is surely to be its new name and team.

Tastemaker also noted in the filing that it has changed its name to Priveterra Acquisition Corp. II, but has so far not changed symbols. Nonetheless, it quietly swapped out management teams on July 3 shifting from officers experienced in the franchise restaurant space to one focused on biotech.

The new team is steered by Chairman and CEO Oleg Grodnensky, managing partner at Priveterra Capital. Grodnensky was also on board with Priveterra I (NASDAQ:PMGM) albeit as CFO and COO.

The rest of Tastemaker’s management and Board has resigned and only the SPAC’s independent directors have been replaced thus far. Life sciences executives Bill Carpou, Dimitri Azar and Cameron Piron and to join the Board as well as its Audit and Compensation Committees.

The first Priveterra SPAC, which IPO’d in February 2021 and announced a combination with AEON Biopharma in December 2022, itself just achieved a successful completion vote on July 3 having adjourned eight times.

The SPAC now known as Priveterra II terminated a combination with jewelry distributor Quality Gold on June 22 and has been struggling to maintain compliance with Nasdaq listing standards since earlier in the month. It has about $29.8 million in trust after seeing 89.4% redemptions thus far.

To keep going with its fresh start, the new team will need to extend its July 12 transaction deadline and the proposal on file would push this to January 12, 2024 in exchange for no new contribution to its trust.

 

Recent Posts
by Nicholas Alan Clayton on 2025-04-24 at 8:22am

At the SPAC of Dawn SPAC momentum has not waned amid the market rally as three more SPACs are angling to price their IPOs by this evening, adding to two others and went public earlier this week. This would bring April’s tally to nine SPAC IPOs after just three in March. It has not been...

by Nicholas Alan Clayton on 2025-04-23 at 6:13pm

New Providence Acquisition Corp. III (NASDAQ:NPACU) announced the pricing of its $261 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “NPACU”, Thursday, April 24, 2025. The new SPAC aims to combine with a consumer target that has the potential to generate attractive risk-adjusted returns. New Providence III’s...

by Nicholas Alan Clayton on 2025-04-23 at 3:59pm

Cantor Equity Partners Inc. (NASDAQ:CEP) has entered into a definitive agreement to combine with Twenty One Capital at an enterprise value of $3.6 billion, or 1x its future net asset value (NAV). Twenty One Capital aims to secure a sizeable Bitcoin holding and leverage it for financial services products as well as Bitcoin-focused media offerings....

by Nicholas Alan Clayton on 2025-04-23 at 12:41pm

Voyager (NASDAQ:VACH) has signed a definitive agreement to combine with biotech firm VERAXA at an enterprise value of $1.38 billion. Heidelberg, Germany-based VERAXA is developing cancer treatments with its most advanced candidate targeting acute myeloid leukemia (AML). The combined company is expected to trade on the Nasdaq under the symbol “VERX” once the deal is...

by Nicholas Alan Clayton on 2025-04-23 at 8:22am

At the SPAC of Dawn SPACs announced two more business combinations and priced a IPO in the past 24 hours showing that activity is going to continue apace regardless of the present market volatility. Another major deal is rumored in the wind with Cantor Equity Partners I (NASDAQ:CEPO) reportedly nearing a major merger that would...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved